Accenture and Synopsys both jumped on the same fear being priced out

Two of Thursday's biggest gainers in the S&P 500 sell very different things. Accenture sells consultants. Synopsys sells the software engineers use to design chips. What they have in common is that both have spent 2026 carrying a discount for the same reason — the suspicion that artificial intelligence erodes demand for what they do — and both spent Thursday having a piece of that discount removed.

Accenture closed up 15.78% at $212.30, its largest single-session gain in years. Intraday quote feeds had it higher still: CNBC's midday screen showed an 18% gain, and other services put the move above 20% at points. Synopsys finished up 12.78% at $490.54.

The Accenture quarter

Fiscal fourth-quarter revenue came in at $18.7 billion, up 7% in local currency. That cleared the top of the company's own $17.75 billion to $18.40 billion guidance range and beat consensus, which was reported at $18.04 billion by one compiler and $18.3 billion by FactSet. Earnings were $3.29 a share against $3.18 expected.

The bookings line is where the signal sat. New bookings totaled $22.2 billion, a book-to-bill ratio of about 1.2 — roughly $1.20 of new work signed for every dollar billed. Within that, the company recorded 141 individual client bookings of $100 million or more, which it described as a quarterly record.

"Capped off another year of broad-based growth across our business," chief executive Julie Sweet said of the fiscal year, adding that the company "reached a new high of 141 quarterly client bookings of $100 million or more."

The forward guidance was not the reason for the move. Fiscal 2027 calls for 3% to 6% local-currency revenue growth, with EPS of $14.39 to $14.81 — a $14.60 midpoint against a $14.67 consensus. First-quarter revenue guidance of $18.95 billion to $19.60 billion has a midpoint a touch under the $19.4 billion analysts expected. A stock that rises 16% on guidance slightly below consensus is telling you something about where the bar was, not where the business is going.

What Synopsys put on the table

Synopsys used an investor day rather than an earnings release. The headline numbers: fiscal 2027 revenue of $11.1 billion to $11.2 billion against an LSEG consensus of $10.81 billion, and EPS of $19.04 to $19.12 versus $17.81 expected. The company targeted roughly 15% compound annual revenue growth from fiscal 2026 through 2030, an adjusted operating margin near 44% in fiscal 2027 rising toward 50% by 2030, and mid-20% compound growth in non-GAAP earnings per share through the end of the decade. Segment targets were at least 13% annual growth in electronic design automation, at least 10% in simulation and analysis and at least 17% in design IP.

Alongside the targets came two agreements. Synopsys said it will share revenue with OpenAI as part of a partnership to build an AI model for chip-design work. Amazon Web Services signed a multi-year deal worth more than $1 billion to license Synopsys chip-design intellectual property. Several brokerages raised price targets on the news.

The structure of those deals is the interesting part for anyone tracking how AI money actually moves. Both are AI customers paying an incumbent toolmaker rather than displacing it — OpenAI buying design expertise it does not have, AWS licensing IP for silicon it is building itself. That is the opposite of the disruption narrative that had been applied to the category.

Why one day does not settle it

Accenture's fiscal 2027 guidance of 3% to 6% local-currency growth is not a boom. It is a services business growing roughly in line with corporate IT budgets, and the bookings have to keep landing for the stock to hold a 16% re-rating. The company is also still integrating the demand shift its clients are making: large AI programs can show up as consulting revenue for a while and then show up as something a client's own platform does.

Synopsys is guiding four years out at an investor day, which is the format with the least accountability attached to it. The OpenAI arrangement is a revenue share on a model that does not exist yet. The AWS licence is real money with a number attached, and that number — a billion dollars over multiple years — is meaningful against roughly $11 billion of annual revenue but is not by itself a growth inflection.

What both moves demonstrate is the mechanics of a crowded fear. When enough of the market has priced a structural threat into a stock, the first quarter that does not confirm the threat produces a move far larger than the operating news justifies. That cuts both ways, and the next print is the one that tests it.